Exelixis | 销售成本



Cost Of Sales 更改 日
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.26M 477K 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.72B 633M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.22B 179.6M 2025-03
Exelixis USD 19.96M 2.64M 2025-01
Genmab DKK 337M 64M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.76B 944M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Sanofi EUR 2.27B 1.81B 2024-12
Takeda JPY 416.87B 22.56B 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Xencor 10.71M 4.56M 2024-09



Exelixis 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.